Svelte Medical Systems, Inc. is pleased to announce that it has
initiated its European clinical trial at the Thoraxcenter Research
Center in Rotterdam, the Netherlands for its “Stent-on-a-Wire” (SOAW)
cobalt–chromium Bare Metal Stent. The SOAW delivery system represents a
more deliverable, very low profile system that can reduce procedural
costs and can potentially lower the rate of stent thrombosis. Professor
Serruys, Chief of Interventional Cardiology at Erasmus Medical center in
the Netherlands commented that “this device will simplify the stenting
procedure and allow us to downsize the guiding catheter in many
patients.” The company anticipates initiating additional trials in
Brazil and Columbia during the first quarter of 2010.
“this device will simplify the stenting
procedure and allow us to downsize the guiding catheter in many
patients.”
The company also plans to introduce its drug eluting stent (DES) with
non-inflammatory properties instead of utilizing typical polymeric
coatings which are known to significantly irritate the vessel lining.
Svelte Medical anticipates receiving CE Mark for the first generation
bare metal SOAW by the middle of 2010 and plans to initiate clinical
activities for the DES in 2011.